DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR GLIPIZIDE
» See Plans and Pricing
All Clinical Trials for Glipizide
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00094770 | An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2004-09-01 | The purpose of this investigational study is to determine the safety and effectiveness of an investigational drug in patients with type 2 diabetes mellitus (a specific type of diabetes). |
| NCT00116831 | Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes | Completed | GlaxoSmithKline | Phase 3 | 2005-01-01 | The purpose of this study is to test the safety and effectiveness of rosiglitazone against a sulfonylurea in reducing or slowing the development of atherosclerosis in the blood vessels of the heart. |
| NCT00509236 | Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2007-10-01 | The purpose of the study is to compare sitagliptin and glipizide in lowering blood sugar in participants with type-2 diabetes mellitus (T2DM) and end-stage renal disease on dialysis who do not have adequate glycemic control. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Glipizide
Condition Name
Clinical Trial Locations for Glipizide
Trials by Country
Clinical Trial Progress for Glipizide
Clinical Trial Phase
Clinical Trial Sponsors for Glipizide
Sponsor Name
